Abiopharma

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sunrun Reports First Quarter 2026 Financial Results

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution

Mirum Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

Nortech Systems Incorporated to Report First Quarter 2026 Financial Results and Hold a Conference Call on May 14, 2026

REGAL REXNORD REPORTS STRONG FIRST QUARTER 2026 FINANCIAL RESULTS

Cirrus Logic Reports Fourth Quarter Revenue of $448.5 Million and Record Full Fiscal Year 2026 Revenue of $2.0 Billion

Recon Receives NASDAQ Notification Regarding Minimum Bid Requirements